Invitation to Submit Proposals under Framework Agreements 173/2022, 436/2023, 481/2023, 491/2023, 780/2024, 1077/2024, 1367/2025, 1428/2025

This tender invites proposals for various pharmaceutical products under multiple framework agreements, specifically agreements numbered 173/2022, 436/2023, 481/2023, 491/2023, 780/2024, 1077/2024, 1367/2025, 1428/2025, and 1589/2025. The categories of medications include a wide range of therapeutic areas such as central nervous system drugs, oncology and immunomodulatory medications, endocrine treatments, and various other pharmaceuticals. Interested parties are encouraged to submit their proposals in accordance with the specified requirements outlined in the framework agreements. The tender aims to ensure the provision of essential medications to meet public health needs. Key requirements for bidders may include compliance with regulatory standards, proof of product efficacy, and competitive pricing. The tender is open to suppliers capable of delivering high-quality pharmaceutical products within the stipulated timelines. This initiative is part of a broader effort to enhance healthcare services and ensure the availability of necessary medications in the healthcare system. All proposals must be submitted by the designated deadline, and further details regarding submission procedures and evaluation criteria will be provided in the tender documentation.

This is a supplies contract in the information and communication technology sector. Located in Portugal, Europe, this opportunity is open to firms and consortiums, with an estimated budget of EUR 169,598.

Published through base_gov_pt, a national government procurement portal. Public procurement tenders follow the country's national bidding regulations and may have specific eligibility and documentation requirements for the supply of goods in the information and communication technology sector. Supply contracts typically require bidders to demonstrate product compliance with technical specifications, delivery capacity, and relevant certifications. This contract has already been awarded. The information is published for transparency and market intelligence purposes.